Preliminary Results from the Multicenter, Randomized Phase III Trial (SCIENCE): Comparing Chemotherapy Plus Sintilimab and Chemoradiotherapy Plus Sintilimab Versus Chemoradiotherapy for Neoadjuvant Treatment in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma.
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined